Peggy Allred

2.2k citations

18 papers · 1.4k indexed · 1 hit paper · h-index 12

Molecular Biology top 10%
Neurology top 2%
Genetics top 2%
Neurology top 2%
Cellular and Molecular Neuroscience top 10%

Co-authors: Alan Pestronk Robert H. Baloh Matthew B. Harms Timothy M. Miller Stanley H. Appel Ericka Simpson Alison Goate Janet Cady
Topics: Amyotrophic Lateral Sclerosis Research (12 papers)Neurogenetic and Muscular Disorders Research (11 papers)biodegradable polymer synthesis and properties (3 papers)
Cited by: Genetics Neurology
Journals: Neurology Annals of Neurology The Lancet Neurology
Partner nations: United States United Kingdom Mexico

In The Last Decade

Peggy Allred

18 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

2013 492 citations Timothy M. Miller, Alan Pestronk et al. The Lancet Neurology profile →

Peers

Countries citing papers authored by Peggy Allred

Since Specialization

Citations

This map shows the geographic impact of Peggy Allred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peggy Allred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peggy Allred more than expected).

Fields of papers citing papers by Peggy Allred

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peggy Allred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peggy Allred. The network helps show where Peggy Allred may publish in the future.

Co-authorship network of co-authors of Peggy Allred

This figure shows the co-authorship network connecting the top 25 collaborators of Peggy Allred. A scholar is included among the top collaborators of Peggy Allred based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peggy Allred. Peggy Allred is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Longitudinal Quantitative MRI Provides Responsive Outcome Measures for Early and Late Muscle Changes in ALS 2024 ·Muscle & Nerve ·Frank Diaz,John S. Thornton,Stephen Wastling,(unknown),Jasper M. Morrow,(unknown),Catherine Bresee,Peggy Allred,Pablo Avalos,Richard A. Lewis,Pamela J. Shaw,Clive N. Svendsen	2
2	Protein kinetics of superoxide dismutase‐1 in familial and sporadic amyotrophic lateral sclerosis 2023 ·Annals of Clinical and Translational Neurology ·Cindy V. Ly,(unknown),Wade Self,James Bollinger,Jennifer Jockel‐Balsarotti,(unknown),Peggy Allred,(unknown),Michael W. Doyle,(unknown),(unknown),(unknown),(unknown),Katherine L. Nicholson,Robert C. Bucelli,Bruce W. Patterson,Randall J. Bateman,Timothy M. Miller	7
3	A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis 2017 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Lora Clawson,Merit Cudkowicz,Lisa S. Krivickas,Benjamin Rix Brooks,Mohammed Sanjak,Peggy Allred,Nazem Atassi,(unknown),(unknown),(unknown),(unknown),Hong Yu,David Schoenfeld,Nicholas J. Maragakis	47
4	Patients with ALS show highly correlated progression rates in left and right limb muscles 2017 ·Neurology ·David J. Rushton,Patricia L. Andres,Peggy Allred,Robert H. Baloh,Clive N. Svendsen	12
5	Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis 2015 ·Neuromuscular Disorders ·Conrad C. Weihl,Robert H. Baloh,Youjin Lee,Tsui‐Fen Chou,Sara K. Pittman,Glenn Lopate,Peggy Allred,Jennifer Jockel‐Balsarotti,Alan Pestronk,Matthew B. Harms	49
6	Pre‐morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis 2015 ·Muscle & Nerve ·Sabrina Paganoni,(unknown),Amy M. Shui,Peggy Allred,Matthew Harms,Jingxia Liu,Nicholas J. Maragakis,David Schoenfeld,Hong Yu,Nazem Atassi,Merit Cudkowicz,Timothy M. Miller	27
7	The TREM2 Variant p.R47H is a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (I5-2.002) 2014 ·Neurology ·Matthew Harms,Janet Cady,Erica Koval,Bruno A. Benítez,Craig M. Zaidman,Jennifer Jockel‐Balsarotti,Peggy Allred,Robert H. Baloh,John Ravits,Ericka Simpson,Stanley H. Appel,Alan Pestronk,Alison Goate,Timothy M. Miller,Carlos Cruchaga	1
8	TREM2Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis 2014 ·JAMA Neurology ·Janet Cady,Erica Koval,Bruno A. Benítez,Craig M. Zaidman,Jennifer Jockel‐Balsarotti,Peggy Allred,Robert H. Baloh,John Ravits,Ericka Simpson,Stanley H. Appel,Alan Pestronk,Alison Goate,Timothy M. Miller,Carlos Cruchaga,Matthew B. Harms	214
9	The TREM2 Variant p.R47H is a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (I5-2.002) 2014 ·Matthew Harms,Janet Cady,Erica Koval,Bruno A. Benítez,Craig M. Zaidman,Jennifer Jockel‐Balsarotti,Peggy Allred,Robert H. Baloh,John Ravits,Ericka Simpson,Stanley H. Appel,Alan Pestronk,Alison Goate,Timothy M. Miller,Carlos Cruchaga	1
10	Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes 2014 ·Annals of Neurology ·Janet Cady,Peggy Allred,Taha Bali,Alan Pestronk,Alison Goate,Timothy M. Miller,Robi D. Mitra,John Ravits,Matthew B. Harms,Robert H. Baloh	150
11	An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studybreakdown → 2013 ·The Lancet Neurology ·Timothy M. Miller,Alan Pestronk,William David,Jeffrey Rothstein,Ericka Simpson,Stanley H. Appel,Patricia L. Andres,Katy Mahoney,Peggy Allred,K. Alexander,Lyle W. Ostrow,David Schoenfeld,Eric A. Macklin,Daniel A. Norris,Georgios Manousakis,Matthew J. Crisp,Richard Smith,C. Frank Bennett,Kathie M. Bishop,Merit Cudkowicz	492
12	Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis 2013 ·Neurobiology of Aging ·Matthew B. Harms,Janet Cady,Craig M. Zaidman,Paul Cooper,Taha Bali,Peggy Allred,Carlos Cruchaga,Michael W. Baughn,(unknown),Alan Pestronk,Alison Goate,John Ravits,Robert H. Baloh	58
13	Exome Sequencing Reveals DNAJB6 Mutations in Dominantly-Inherited Myopathy (S55.004) 2012 ·Neurology ·(unknown),R. Brian Sommerville,Peggy Allred,Shaughn Bell,(unknown),Paul Cooper,Glenn Lopate,Alan Pestronk,(unknown),(unknown)	2
14	Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy 2012 ·Neurology ·Matthew B. Harms,Kassandra M Ori-McKenney,Mariacristina Scoto,(unknown),Sue Bell,Deqin Ma,Salvatore Masi,Peggy Allred,M. Al-Lozi,Mary M. Reilly,Laurence Miller,Agnes Jani‐Acsadi,Alan Pestronk,Michael E. Shy,Francesco Muntoni,Richard B. Vallee,Robert H. Baloh	148
15	Results of a Phase 1, Double-Blind, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of ISIS 333611 Administered Intrathecally to Patients with Familial ALS Due to SOD1 Gene Mutations (S25.001) 2012 ·Neurology ·Timothy M. Miller,Richard Smith,(unknown),William David,Jeffrey D. Rothstein,Elizabeth Simpson,Patricia L. Andres,Katy Mahoney,Peggy Allred,K. Alexander,Kathie M. Bishop,David Schoenfeld,Eric A. Macklin,Daniel A. Norris,C. Frank Bennett,Merit Cudkowicz	4
16	Exome sequencing reveals DNAJB6 mutations in dominantly‐inherited myopathy 2011 ·Annals of Neurology ·Matthew B. Harms,R. Brian Sommerville,Peggy Allred,Shaughn Bell,Duanduan Ma,Paul R. Cooper,Glenn Lopate,Alan Pestronk,Conrad C. Weihl,Robert H. Baloh	124
17	Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutation 2010 ·Amyotrophic Lateral Sclerosis ·Glenn Lopate,Robert H. Baloh,Muhammad Al‐Lozi,Timothy M. Miller,J. Americo Fernandes Filho,(unknown),(unknown),Julaine Florence,Jeanine Schierbecker,Peggy Allred	30
18	Dominant spinal muscular atrophy with lower extremity predominance 2010 ·Neurology ·Matthew B. Harms,Peggy Allred,R. J. M. Gardner,J. Americo Fernandes Filho,Julaine Florence,Alan Pestronk,M. Al-Lozi,Robert H. Baloh	44

About Peggy Allred

Peggy Allred is a scholar working on Genetics, Neurology and Neurology, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (12 papers), Neurogenetic and Muscular Disorders Research (11 papers) and biodegradable polymer synthesis and properties (3 papers). The work is most often cited by research in Genetics (566 citations), Neurology (663 citations) and Neurology (343 citations). Peggy Allred has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Alan Pestronk, Robert H. Baloh, Matthew B. Harms, Timothy M. Miller, Stanley H. Appel, Ericka Simpson, Alison Goate, Janet Cady, John Ravits and David Schoenfeld. Their work appears in journals such as Neurology, Annals of Neurology and The Lancet Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact